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Purpose. To present a unique case of Non-Hodgkin’s-Lymphoma- (NHL) associated compressive optic neuropathy. Method.A n
89-year-old male presenting with acute unilateral visual loss and headache. Results. Patient was initially diagnosed with occult
giant cell arteritis; however after visual acuity deteriorated despite normal inﬂammatory markers, an urgent MRI scan revealed an
extensive paranasal sinus mass compressing the optic nerve. Conclusion. Paranasal sinus malignancies occasionally present to the
ophthalmologist with signs of optic nerve compression and must be included in the diﬀerential diagnosis of acute visual loss.
1.Introduction
Paranasal sinus lymphoma is an uncommon malignancy
which poses signiﬁcant diagnostic challenges. Often diﬃcult
to diagnose, paranasal mass lesions can potentially cause vis-
ual loss by compressing the optic nerve, but only a few such
cases have ever been reported in the literature [1–5].
2. Case Presentation
An 89-year-old male was seen in the eye clinic with a one-
week history of painless visual loss in the left eye along with a
recent onset of left-sided headache and malaise. A thorough
systemichistoryfailedtorevealanyothersymptoms.Hispast
ocular history included bilateral pseudophakia whilst he was
on medication for hypertension, asthma, and hiatus hernia.
Examination revealed a VA of 6/150 (1.36 LOGMAR) in the
lefteyewithreducedcolourvision(nocolourplatescorrectly
identiﬁed on the Ishihara chart). A left relative aﬀerent
pupillary defect was detected but neuroophthalmological ex-
amination was otherwise unremarkable. Anterior segment
examination was normal with clear media and well-centred
intraocular lenses. Right fundal examination was unremark-
able whilst the left fundus exam revealed pallor of the left
optic disc (Figure 1). Fundus ﬂuorescein angiography and
macular optical coherence tomography were unremarkable.
Left temporal and frontal tenderness was also noted but
lymphadenopathy could not be elicited. Blood tests revealed
a normal full blood count, electrolytes, ESR (19mm/hour),
and CRP (2.0mg/L).
A provisional diagnosis of occult giant cell arteritis was
made and the patient was started on 1mg/kg of oral pred-
nisolone. A temporal artery biopsy arranged 5 days later fail-
ed to demonstrate any arteritic or granulomatous changes.
At this stage a CT of head and orbit was ordered which was
reported as showing no orbital or intracranial abnormalities.
The patient initially responded well to the corticosteroid
treatment with the VA improving to 6/19 (0.5 LOGMAR) a
week later. The patient was then monitored and the dose of
steroid tapered but the established diagnosis was questioned
when the visual acuity declined to 6/60 (1.02 LOGMAR) and
theopticdiscpallorprogresseddespitenormalinﬂammatory
markers.Atthisstageaprogressiveopticneuropathywassus-
pected and an urgent MRI scan organised which revealed a
large soft tissue lesion within the left paranasal sinuses cen-
tred on the ethmoidal air cells with narrowing of the medial
wall of the orbit causing optic nerve distortion and compres-
sion (Figure 2).
AnurgentbiopsywasarrangedwiththeENTteamwhich
showed aggressive diﬀuse large B-cell NHL. The patient was2 Case Reports in Ophthalmological Medicine
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Figure 1: Fundal examination reveals a pale left optic nerve.
(a) (b)
Figure 2: MRI scan shows an abnormal soft tissue lesion within the left paranasal sinuses centered on the ethmoid air cells. Note the
distortion of the medial wall of the orbit and narrowing of the orbital apex causing distortion and compression of the left optic nerve.
referred to a tertiary centre for treatment and has done well
with 3 courses of CHOP (cyclophosphamide, doxorubicin,
vincristine, and prednisolone) chemotherapy and involved
ﬁeld radiotherapy.
3. Discussion
Lymphomas represent a group of malignant neoplasms of
lymphoreticularoriginwhicharedividedintoHodgkin’sdis-
easeandNHL[6].ThemajorityofheadandneckNHLsorig-
inate from extranodular sites such as lymphoid tissue of
Waldeyer’s tonsillar ring [7] whilst lymphomas of the nasal
cavity and paranasal sinuses are rare, accounting for only
0.17% of all lymphomas [8]. Patients are usually elderly
males often with locally advanced tumours [9]. The majority
of sinonasal lymphomas are of a diﬀuse B-cell origin and
are classiﬁed as stage E1 according to the Ann Arbor system
[10, 11].
Inonecaseseriesthesymptomsreportedbypatientswith
paranasal sinus lymphoma were nasal obstruction (100%),
epistaxis (58%), headaches resistant to analgesia (50%), fac-
ial swelling (50%), palatal lesion (42%), and diplopia (17%)
[9].
Orbital invasion is a common manifestation of sinus ma-
lignancy with frequent presenting signs and symptoms in-
clude proptosis, dystopia, visual loss, lid oedema, extraoc-
ular movement limitation, diplopia, conjunctival chemosis/
injection, eye pain, and photophobia [1].
Treatmentoptions forsinonasallymphomasincluderad-
iation and chemotherapy with some studies showing pref-
erence with radiation alone in early disease stages [12, 13],
whilst others propose a combined treatment regimen that
oﬀers an improved disease-free survival and overall survival
rates [14].
Despite treatment paranasal sinus lymphoma carries a
poor prognosis (50% 5-year survival rate) often due to a de-
layindiagnosisastumorsinthisareaareoftenasymptomaticCase Reports in Ophthalmological Medicine 3
initially and are at an advanced stage at the time of diagnosis
[1].
Ophthalmological symptoms and signs often occur early
in its natural history as a result of the close proximity of the
orbital structures to the paranasal sinuses. The ophthal-
mologist’s role therefore is one of upmost importance in
recognisingtheclinicalredﬂagsassociatedwithocularmani-
festations of this malignancy and in ensuring a multidisci-
plinary approach in patient investigation, management, and
followup.
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